Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-15

Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients Not Adequately Responding to Aliskiren Alone [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated whether adding amlodipine to aliskiren improves blood pressure control in hypertension patients not adequately responding to aliskiren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aliskiren (Aliskiren)
  • Amlodipine (amlodipine)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-06-15